Abbott Laboratories gifted Howard University with $1 million to fund scholarships for medical students interested in pursuing a career in clinical research. The money would cover eight scholarships or $25,000 each, to be awarded between 2022 and 2025.
Aside from the gift to Howard University, Abbott also dedicated $5 million to establish scholarships at historically Black universities and colleges (HBCUs) and other minority nursing associations. It is part of the company’s efforts to enhance clinical trial diversity.
Hugh Mighty, the dean of the College of Medicine at Howard, said inequities in care are closely tied to underrepresentation in research.
Abbott president and CEO Robert Ford stressed the importance for clinical trials to remain representative of the people the products were designed to help. He intends to continue working to break down barriers to participation in clinical trials to help more people have greater access to therapies that have the potential to change lives.